Pfizer and Astellas announce positive results from phase 3ev-303 clinical trial for Padcev in combination with Keytruda - TradingView

Reuters | Oct. 18, 2025, 10:30 a.m. | Original
Pfizer and Astellas announce positive results from phase 3ev-303 clinical trial for Padcev in combination with Keytruda TradingView
Taiwan opposition party's firebrand new leader pledges peace with China - Reuters Kering nears $4 billion sale of beauty unit to L'Oreal, WSJ reports - Reuters